China Pharma Holdings, Inc. (NYSE American: CPHI) (“China Pharma,” the “Company” or “We”), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China,...
BioAtla, Inc, a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, today announced financial results for the second quarter...
Mahana Therapeutics has secured $61m in Series B financing to support commercialisation and further development of digital therapeutics. The funds will be used by the company...
Glenmark Pharmaceuticals Limited, a research‐led global integrated pharmaceutical company, today announced its financial results for the first quarter ended June 30, 2021. For the First Quarter...
Moderna Inc. and BioNTech SE, the world’s leading Covid-19 vaccine makers, tumbled for the second day in a row, losing roughly $60 billion in combined market...
Philip Morris International Inc. today announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) treatment for acute...
US-based silicon photonics technology company Rockley Photonics has completed the business combination with SC Health. Rockley has secured $167.8m in gross proceeds, as a result of...
Vensica Therapeutics (“Vensica”), a clinical stage biopharmaceutical company, announced that it has signed a strategic collaboration agreement with Merz Therapeutics, a business of the Merz Group...
Samsung NeuroLogica announced that the U.S. Defense Health Agency (DHA) has granted authority-to-operate (ATO) status for its RS85 Prestige ultrasound scanner. Achieve ATO designation allows RS85...
3NT Medical, a medtech innovator dedicated to developing single-use specialized endoscopes for the diagnosis and treatment of ear, nose and throat (ENT) disorders, today announced FDA...
Inari Medical, Inc. a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported...
Bexson Biomedical announced today that it launched an R&D initiative to develop subcutaneous formulations of psychoactive therapeutics. Santa Barbara, Calif.-based Bexson’s effort will apply its existing...
Lunit said Thursday that the medical artificial intelligence company and global medical device maker, Fujifilm, have co-developed an AI-based chest X-ray analysis system and won approval...
Nevro Corp. a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the company will report...
Titan Medical Inc, a medical device company focused on the development and commercialization of its innovative surgical technologies for robotic single access surgery, today announced financial...
Copyright © 2024 Medical Buyer